Company news
Orthocell Ltd news in 2022
Orthocell Ltd's news releases, calls and decks from 2022, newest first.
Remplir Gains Australian Reimbursement
October 31, 2022
OrthoATI Rotator Cuff Study Success With Cross-Over Patients
September 28, 2022
First orders for Striate and Remplir
September 26, 2022
Appointment of Exclusive Australian Distributor for Remplir
September 7, 2022
Final Report and Annual Report to Shareholders
August 30, 2022
Striate Global License and Distribution Agreement Update
July 20, 2022
OCC Signs Striate Global License And Manufacturing Agreement
June 27, 2022
Final Data Readout for Orthocells Nerve Reconstruction Study
June 6, 2022
Orthocell Receives A$2.1m R&D Tax Incentive Refund
June 2, 2022
Notification regarding unquoted securities - OCC
April 21, 2022
Regulatory Approval for Remplir Nerve Repair Device
March 20, 2022
Striate US Market Entry Update
February 27, 2022
Decks in 2022
- Argonaut Biotech Briefing and AusBioInvest 2022
Conference · 21 slides · Oct 26, 2022
- Euroz Hartleys Healthcare Conference (July 2022)
Conference · 27 slides · Jul 27, 2022